These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8482836)

  • 1. T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues.
    Ostrov D; Krieger J; Sidney J; Sette A; Concannon P
    J Immunol; 1993 May; 150(10):4277-83. PubMed ID: 8482836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation.
    Chen YZ; Matsushita S; Nishimura Y
    J Immunol; 1996 Nov; 157(9):3783-90. PubMed ID: 8892606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R; Hill CM; Hayball JD; Lamb JR; Rothbard JB
    J Immunol; 1991 Aug; 147(4):1292-8. PubMed ID: 1869824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping T cell recognition: the identification of a T cell receptor residue critical to the specific interaction with an influenza hemagglutinin peptide.
    Wedderburn LR; Searle SJ; Rees AR; Lamb JR; Owen MJ
    Eur J Immunol; 1995 Jun; 25(6):1654-62. PubMed ID: 7614994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of HLA-DR residues at positions 67, 71, and 86 in interaction between HLA-DR11 and peptide HA306-320.
    Zeliszewski D; Golvano JJ; Gaudebout P; Dorval I; Freidel C; Gebuhrer L; Betuel H; Borras-Cuesta F; Sterkers G
    J Immunol; 1993 Dec; 151(11):6237-47. PubMed ID: 7504016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopeptide-specific T cell reactivity altered by peptide analogs.
    Colovai AI; Liu Z; Harris PE; Cortesini R; Suciu-Foca N
    J Immunol; 1997 Jan; 158(1):48-54. PubMed ID: 8977174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of different T cell lines specific for the same antigen with TCR antagonist peptides.
    Snoke K; Alexander J; Franco A; Smith L; Brawley JV; Concannon P; Grey HM; Sette A; Wentworth P
    J Immunol; 1993 Dec; 151(12):6815-21. PubMed ID: 7505016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor gene segment utilization by HLA-DR1-alloreactive T cell clones.
    Geiger MJ; Gorski J; Eckels DD
    J Immunol; 1991 Oct; 147(7):2082-7. PubMed ID: 1833450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation.
    Hurley CK; Steiner N; Wagner A; Geiger MJ; Eckels DD; Rosen-Bronson S
    J Immunol; 1993 Feb; 150(4):1314-24. PubMed ID: 8381833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.
    Doherty DG; Penzotti JE; Koelle DM; Kwok WW; Lybrand TP; Masewicz S; Nepom GT
    J Immunol; 1998 Oct; 161(7):3527-35. PubMed ID: 9759873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique T cell antagonist properties of the exact self-correlate of a peptide antigen revealed by self-substitution of non-self-positions in the peptide sequence.
    Schountz T; Kasselman JP; Ford SR; Murray JS
    Cell Immunol; 1996 Mar; 168(2):193-200. PubMed ID: 8640865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific T cells with monogamous or promiscuous restriction patterns are sensitive to different HLA-DR beta chain substitutions.
    Karr RW; Panina-Bordignon P; Yu WY; Lanzavecchia A
    J Immunol; 1991 Jun; 146(12):4242-7. PubMed ID: 2040799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual effects of the DR11-variable beta-chain residues 67, 71, and 86 upon DR(alpha,beta 1*1101)-restricted, peptide-specific T cell proliferation.
    McKinney JS; Fu XT; Swearingen C; Klohe E; Karr RW
    J Immunol; 1994 Dec; 153(12):5564-71. PubMed ID: 7989758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of thymocyte negative selection by T cell receptor antagonist peptides.
    Williams O; Tanaka Y; Bix M; Murdjeva M; Littman DR; Kioussis D
    Eur J Immunol; 1996 Mar; 26(3):532-8. PubMed ID: 8605917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements of peptide and MHC for DR(alpha, beta 1*0401)-restricted T cell antigen recognition.
    McNicholl JM; Whitworth WC; Oftung F; Fu X; Shinnick T; Jensen PE; Simon M; Wohlhueter RM; Karr RW
    J Immunol; 1995 Aug; 155(4):1951-63. PubMed ID: 7636246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
    Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides.
    Newton-Nash DK; Eckels DD
    J Immunol; 1993 Mar; 150(5):1813-21. PubMed ID: 7679697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation.
    Cheng YJ; Zhou Q; Li ZG
    Scand J Immunol; 2005 Mar; 61(3):260-5. PubMed ID: 15787743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition.
    Krieger JI; Karr RW; Grey HM; Yu WY; O'Sullivan D; Batovsky L; Zheng ZL; Colón SM; Gaeta FC; Sidney J
    J Immunol; 1991 Apr; 146(7):2331-40. PubMed ID: 1706393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous involvement of all six predicted antigen binding loops of the T cell receptor in recognition of the MHC/antigenic peptide complex.
    Kasibhatla S; Nalefski EA; Rao A
    J Immunol; 1993 Sep; 151(6):3140-51. PubMed ID: 8376771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.